1.
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.
2.
3.
4.
5.
6.
7.
8.
9.
Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.
Seasonal coronavirus protective immunity is short-lasting.
Future challenges for clinical care of an ageing population infected with HIV: a modelling study